Condition: Asthma
Intervention: Drug: inhaled corticosteroids (usually budesonide/fomorterol 160/4.5mcg; fluticasone/salmeterol 250/50mcg)
Sponsor: Guangzhou Institute of Respiratory Disease
Completed – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days